Matthew L. Posard

Director at HALOZYME THERAPEUTICS, INC.

CIK: 1159036

11

Total trades

8

Buys

2

Sells

May 5, 2026

Last trade

Date	Stock	Type	Shares	Value	Src
May 5, 2026	HALOHALOZYME THERAPEUTICS, INC.	Buy	6,040	–
May 5, 2026	HALOHALOZYME THERAPEUTICS, INC.	Buy	3,796	–
May 5, 2026	HALOHALOZYME THERAPEUTICS, INC.	Buy	6,040	–
May 5, 2026	HALOHALOZYME THERAPEUTICS, INC.	Buy	3,796	–
May 5, 2026	HALOHALOZYME THERAPEUTICS, INC.	Buy	3,796	–
May 5, 2026	HALOHALOZYME THERAPEUTICS, INC.	Buy	6,040	–
May 5, 2026	HALOHALOZYME THERAPEUTICS, INC.	Buy	3,796	–
May 5, 2026	HALOHALOZYME THERAPEUTICS, INC.	Buy	6,040	–
Apr 6, 2026	HALOHALOZYME THERAPEUTICS, INC.	Sell	4,100	$262K
Apr 6, 2026	HALOHALOZYME THERAPEUTICS, INC.	Option	10,000	$121K
Apr 6, 2026	HALOHALOZYME THERAPEUTICS, INC.	Sell	5,900	$373K

Matthew L. Posard – Insider Trading Activity | DataHeimdall